Immunomedics, Inc. Gains 99.79%
Mon 06 Apr 20 at 05:30 PM
Immunomedics, Inc. (IMMU:NASDAQ) soared at $18.78, representing a gain of 99.8%. On Fri 03 Apr 20, IMMU:NASDAQ touched a New 2-Week Low of $9.4. The stock got featured on our News Catalysts scanner on Fri 03 Apr 20 at 06:57 PM in the 'BIOTECH' category. From Fri 20 Mar 20, the stock recorded 50.00% Up Days and 63.64% Green Days
About Immunomedics, Inc. (IMMU:NASDAQ)
Immunomedics Inc is a clinical-stage biopharmaceutical company. The Company is engaged in developing monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases.
Top 10 Gainers:
- Akers Biosciences, Inc. (AKER:NASDAQ), 146.84%
- Immunomedics, Inc. (IMMU:NASDAQ), 99.79%
- Exantas Capital Corp. (XAN:NYSE), 57.55%
- Aeterna Zentaris Inc. (AEZS:NASDAQ), 55.72%
- Associated Capital Group, Inc. (AC:NYSE), 48.82%
- Mesoblast Limited (MESO:NASDAQ), 46.67%
- Atossa Therapeutics, Inc. (ATOS:NASDAQ), 44.23%
- Braemar Hotels & Resorts, Inc. (BHR:NYSE), 43.55%
- Pensare Acquisition Corp. (WRLS:NASDAQ), 43.33%
- Cherry Hill Mortgage Investment Corporation (CHMI:NYSE), 41.52%